Connect Biopharma (CNTB) announced the expansion of the size of its Board of Directors from six to seven directors and the appointment of Jim Schoeneck as a director effective today.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNTB:
- Northland starts Connect Biopharma at Outperform on chance to define new class
- Connect Biopharma initiated with an Outperform at Northland
- Connect Biopharma Ends ADS Agreement with Deutsche Bank
- Connect Biopharma plans to terminate ADR program, list shares on Nasdaq
- Connect Biopharma Regains Nasdaq Compliance